ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 1 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $15,067,000 | -63.6% | 798,873 | -77.3% | 0.37% | -58.1% |
| Q2 2019 | $41,405,000 | -4.8% | 3,517,856 | +10.4% | 0.87% | -15.0% |
| Q1 2019 | $43,488,000 | +50.5% | 3,185,983 | +13.0% | 1.03% | +49.6% |
| Q4 2018 | $28,892,000 | -9.4% | 2,818,788 | +47.2% | 0.69% | -4.7% |
| Q3 2018 | $31,879,000 | +23.4% | 1,914,690 | +17.1% | 0.72% | +19.4% |
| Q2 2018 | $25,834,000 | +261.3% | 1,635,035 | +190.4% | 0.60% | +284.7% |
| Q1 2018 | $7,151,000 | +89.8% | 563,037 | +210.8% | 0.16% | +80.5% |
| Q1 2017 | $3,768,000 | +0.6% | 181,143 | +0.6% | 0.09% | +2.4% |
| Q4 2016 | $3,744,000 | – | 180,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $37,365,000 | 8.14% |
| Foresite Capital Management II, LLC | 1,686,220 | $21,415,000 | 7.12% |
| Foresite Capital Management IV, LLC | 830,919 | $10,553,000 | 4.38% |
| SENZAR ASSET MANAGEMENT, LLC | 822,890 | $10,451,000 | 3.30% |
| Redmile Group, LLC | 6,505,766 | $82,623,000 | 3.19% |
| DAFNA Capital Management LLC | 396,013 | $5,029,000 | 2.45% |
| SECTORAL ASSET MANAGEMENT INC | 863,600 | $10,968,000 | 1.20% |
| Palo Alto Investors LP | 1,849,832 | $23,493,000 | 1.00% |
| Bellevue Group AG | 700,464 | $8,896,000 | 0.88% |
| Rock Springs Capital Management LP | 1,529,800 | $19,428,000 | 0.83% |